0      0

29th Annual North American Cystic Fibrosis Conference

W04: INF/MIC: Epidemiology & Management of Infection

Oct 8, 2015 10:00am ‐ Oct 8, 2015 11:45am

Standard: $49.99


Observations in respiratory microbiology are presented, including factors associated with Burkholderia spp. eradication & NTM acquisition. Emphasis on P. aeruginosa (Pa) will include trends in aztreonam susceptibility, response to combined tobramycin & azithromycin & analyses describing stages of infection with mucoid Pa. Ivacaftor's effect on the microbiome in 'Celtic' G551D is presented.

Educational Objectives:

  1. Describe current trends in P. aeruginosa infection in CF & variable response to common therapeutics including antibiotics & CFTR modulators.
  2. Explain environmental risk factors for non-tuberculosis mycobacteria & potentially successful eradication regimens for Burkholderia.
  3. Use observations of the complex respiratory microbiome to improve CF care.


You must be logged in and own this session in order to post comments.